Drug recall
Micardis Tablets, (telmisartan Tablets) 80 mg, 30 ct. per folding cartons, Rx only, NDC 0597-0041-37)…
FDA recall event 87856 · Class II · Boehringer Ingelheim Pharmaceuticals, Inc.
Key facts
| Event ID | 87856 |
|---|---|
| Recall numbers | D-0600-2021 |
| Recalling firm | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Product type | Drugs |
| Products | Micardis Tablets, (telmisartan Tablets) 80 mg, 30 ct. per folding cartons, Rx only, NDC 0597-0041-37), Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Subpotent Drug |
| Initiation date | May 4, 2021 |
| Report date | Jun 9, 2021 |
| Termination date | Oct 14, 2021 |
| City | Ridgefield |
| State | CT |
| Country | United States |
| FEI number | 1219205 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: